BioMarin Pharmaceutical Inc. (BMRN): Price and Financial Metrics

BMRN POWR Grades

• BMRN scores best on the Value dimension, with a Value rank ahead of 82.53% of US stocks.
• BMRN's strongest trending metric is Value; it's been moving down over the last 179 days.
• BMRN ranks lowest in Momentum; there it ranks in the 12th percentile.

BMRN Stock Summary

• Biomarin Pharmaceutical Inc's market capitalization of $14,641,598,809 is ahead of 84.74% of US-listed equities.
• The price/operating cash flow metric for Biomarin Pharmaceutical Inc is higher than 89.14% of stocks in our set with a positive cash flow.
• In terms of twelve month growth in earnings before interest and taxes, Biomarin Pharmaceutical Inc is reporting a growth rate of 361.18%; that's higher than 93.93% of US stocks.
• If you're looking for stocks that are quantitatively similar to Biomarin Pharmaceutical Inc, a group of peers worth examining would be GTHX, AAOI, IVAC, FORM, and INSG.
• Visit BMRN's SEC page to see the company's official filings. To visit the company's web site, go to www.biomarin.com.

BMRN Valuation Summary

• BMRN's price/sales ratio is 8.1; this is 113.16% higher than that of the median Healthcare stock.
• Over the past 243 months, BMRN's price/sales ratio has gone down 31.8.
• BMRN's price/sales ratio has moved down 31.8 over the prior 243 months.

Below are key valuation metrics over time for BMRN.

BMRN Growth Metrics

Its 3 year cash and equivalents growth rate is now at 34.73%.
• Its 2 year net cashflow from operations growth rate is now at 201.39%.
• Its 3 year price growth rate is now at -1.35%.

Over the past 34 months, BMRN's revenue has gone up $327,765,000.

The table below shows BMRN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	1,846.275	304.536	-64.08
2021-09-30	1,848.582	279.972	15.917
2021-06-30	1,916.624	269.118	837.214
2021-03-31	1,844.416	214.071	795.09
2020-12-31	1,860.455	85.365	859.1
2020-09-30	1,862.781	156.092	852.025

BMRN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BMRN has a Quality Grade of C, ranking ahead of 36.95% of graded US stocks.
• BMRN's asset turnover comes in at 0.314 -- ranking 144th of 682 Pharmaceutical Products stocks.
• APVO, IRWD, and AVEO are the stocks whose asset turnover ratios are most correlated with BMRN.

The table below shows BMRN's key quality metrics over time.